Business29 Aralık 2025Verastem, KRAS G12C akciğer kanseri denemesini sonlandırıp G12D’ye odaklanıyorSOURCE:Investing Türkiye|BY:Investing.comFailed to fetch content: Request failed with error code 403Share:Read Original Article →